Maroondah BreastScreen
Ringwood East, Victoria, 3135, Australia
NCT Number: NCT06019442
Alcohol is a major modifiable risk factor for female breast cancer; yet, awareness of this risk remains surprisingly low and is not systematically addressed in healthcare settings. This study aim to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.
Looking for future studies?
Notify Me40 year and older
Female
Interventional
Not applicable
Ringwood East, Victoria, 3135, Australia
Alcohol is a major modifiable risk factor for female breast cancer, even in very low amounts. In Australia, alcohol consumption accounts for 6.6 per cent of cases in post-menopausal women, and 18 per cent of breast cancer deaths. Yet, awareness of this risk remains low and is not systematically addressed in healthcare settings. Embedding a brief alcohol intervention within lifestyle information offered to all women attending breast screening provides the opportunity to address harmful drinking in a discrete, non-judgmental way, to prevent alcohol-attributable breast cancer among this at-risk population.
Brief alcohol interventions are short, single-session programs typically offered in general practice settings to gather information on a person's alcohol consumption and, in a non confrontational way, provide strategies and motivate change to reduce consumption and related risk of harm. An automated brief alcohol intervention, self-completed on a device such as an iPad, is a low-cost, labour- and time-efficient approach that overcomes many of the issues of providing intervention within busy healthcare environments.
Building on the previous pilot trial of a prototype brief e-health intervention (which included alcohol-related questions asked by a researcher, and an animation viewed on an iPad that was activated by the researcher), the aim of the current study is to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Embedded within the lifestyle health promotion provided in both conditions, participants randomised to the experimental condition will receive a brief alcohol intervention. The brief alcohol intervention will comprise information and behaviour-change content regarding alcohol consumption, including: messaging around alcohol risks/harms (with a focus on alcohol use and breast cancer risk), positive-framed messaging on the health benefits of reducing alcohol intake, and alcohol harm-reduction / behaviour change strategies (e.g. drink counting, goal setting, behaviour substitution, problem solving).
Post-session information will be provided via email (i.e. electronic brochure summarising brief alcohol intervention content).
Lifestyle health promotion, focused on physical activity and maintaining a healthy weight for reducing breast cancer risk, will be provided.
Post-session information will be provided via email (i.e. electronic brochure summarising nutrition for maintaining a healthy weight).
Time frame: immediately post-randomisation
Change in next-month drinking intentions (5-point scale: 1, not at all; 5, to a very large extent)
Time frame: 4-weeks post-randomisation
Change in next-month drinking intentions (5-point scale: 1, not at all; 5, to a very large extent)
Time frame: 4-weeks post-randomisation
Change in intended number of standard drinks consumed over the next month (composite of intention frequency/quantity response items)
Time frame: immediately post-randomisation
Proportion of participants intending to reduce their next-month alcohol consumption (5-point scale: 1, not at all; 5, to a very large extent)
Time frame: 4-weeks post-randomisation
Proportion of participants intending to reduce their next-month alcohol consumption (5-point scale: 1, not at all; 5, to a very large extent)
Time frame: 4-weeks post-randomisation
Proportion of participants accurately identifying alcohol as a clear risk factor for breast cancer
Time frame: 4-weeks post-randomisation
Proportion of participants accurately identifying i) the increased breast cancer risk associated with drinking one average restaurant serve of wine a day; ii) the number of standard drinks in an average restaurant serve of red wine; iii) the maximum number of standard drinks per week recommended by current Australian Alcohol Guidelines (multiple-choice questions)
Time frame: 4-weeks post-randomisation
Among women who have had an alcohol drink in the past month, change in alcohol consumption (composite of frequency/quantity response items)
Time frame: 4-weeks post-randomisation
Proportion of participants accurately identifying inactivity and excess weight as risk factors for breast cancer
Turning Point
Other
An Electronic Brief Intervention to Reduce Alcohol Consumption Intentions, Improve Alcohol Literacy, and Reduce Harmful Use Among Women Attending a Breast Screening Service: a Randomised Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04715516
Alcohol Consumption, Alcohol Drinking
Ringwood East, Victoria, Australia
View Trial DetailsNCT06224712
Behavior, Health Behavior
Devadurga, India
View Trial DetailsNCT05120869
Behavior, COVID-19
Las Cruces, New Mexico, United States
View Trial DetailsNCT06098690
Adherence, Patient, Behavior
El Paso, Texas, United States
View Trial Details